Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Phosphodiesterase 5 Inhibitors (PDE5i) (Sildenafil) in Management of Distal Ureteral Stone

NCT02519153 is registered in ClinicalTrials.gov with Mansoura University as lead sponsor.

NCT NCT02519153
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02519153 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Phosphodiesterase 5 Inhibitors (PDE5i) (Sildenafil) in Management of Distal Ureteral Stone
Lead sponsor
Mansoura University
Phase
Phase 4
Overall status
Unknown status
Start date
July 31, 2014
Completion date
September 30, 2017
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ureteral stone, urolithiasis